A new method of identifying glioblastoma subtypes and creation of corresponding animal models

Oncogene
Xia ZhouXudong Zhao

Abstract

Glioblastoma (GBM) accounts for up to 50% of brain parenchymal tumors. It is the most malignant type of brain cancer with very poor survival and limited remedies. Cancer subtyping is important for cancer research and therapy. Here, we report a new subtyping method for GBM based on the genetic alterations of CDKN2A and TP53 genes. CDKN2A and TP53 are the most frequently mutated genes with mutation rates of 60 and 30%, respectively. We found that patients with deletion of CDKN2A possess worse survival than those with TP53 mutation. Interestingly, survival of patients with both TP53 mutation and CDKN2A deletion is no worse than for those with only one of these genetic alterations, but similar to those with TP53 mutation alone. Next, we investigated differences in the gene expression profile between TP53 and CDKN2A samples. Consistent with the survival data, the samples with both TP53 mutation and CDKN2A deletion showed a gene expression profile similar to those samples with TP53 mutation alone. Finally, we found that activation of RAS pathway plus Cdkn2a/b silencing can induce GBM, in a similar way to tumor induction by RAS activation plus TP53 silencing. In conclusion, we show that the genetic alterations of CDKN2A and TP53 may b...Continue Reading

References

Oct 6, 2004·Genome Biology·Robert C GentlemanJianhua Zhang
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Oct 29, 2005·Journal of Neuropathology and Experimental Neurology·Shumin DongDavid N Louis
May 18, 2006·Molecular and Cellular Biology·Gerson RothschildAnna Lasorella
Jul 14, 2006·BMC Biotechnology·Martine GeraertsRik Gijsbers
Jun 7, 2007·Genesis : the Journal of Genetics and Development·Teresa GallardoDiego H Castrillon
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 6, 2009·Nature Medicine·Tomotoshi MarumotoInder M Verma
Apr 20, 2010·Cancer Cell·Houtan NoushmehrUNKNOWN Cancer Genome Atlas Research Network
Aug 17, 2010·Trends in Genetics : TIG·Wenfeng QianJianzhi Zhang
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 2, 2011·International Journal of Ayurveda Research·Manish Kumar GoelJugal Kishore
Sep 29, 2011·The Journal of Clinical Investigation·James C LeeKenneth G C Smith
Mar 6, 2012·Nature Methods·Ben Langmead, Steven L Salzberg
Oct 23, 2012·Science·Dinorah Friedmann-MorvinskiInder M Verma
Nov 30, 2012·IEEE Transactions on Cybernetics·Yanchi LiuSen Wu
Dec 18, 2012·The Journal of Clinical Investigation·Francesco NiolaAnna Lasorella
Feb 23, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sandra H E Boots-SprengerPieter Wesseling
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jan 15, 2014·Histopathology·Svetlana N PopovaIrina Alafuzoff
May 29, 2014·BioMed Research International·Gergana StanchevaNikolay Gabrovsky
Jan 22, 2015·Nucleic Acids Research·Matthew E RitchieGordon K Smyth
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew MistryUri Tabori
Jun 11, 2015·The New England Journal of Medicine·Jeanette E Eckel-PassowRobert B Jenkins
Dec 25, 2015·Nature·William A FlavahanBradley E Bernstein
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE7696

Methods Mentioned

BETA
RNA-seq
PCR

Software Mentioned

vegan
survival
Consensus Cluster Plus
ascadeKM
Bowtie
FastQC
ensemble
R
sigclust Package in
gplots

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.